HA
HC Advisors Portfolio holdings
AUM
$142M
This Quarter Return
+5.39%
1 Year Return
+15.52%
3 Year Return
+52.19%
5 Year Return
+78.78%
10 Year Return
–
AUM
$124M
AUM Growth
+$124M
(+2.7%)
Cap. Flow
-$482K
Cap. Flow
% of AUM
-0.39%
Top 10 Holdings %
Top 10 Hldgs %
66.24%
Holding
90
New
11
Increased
23
Reduced
30
Closed
14
Top Buys
| 1 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
$8.97M |
| 2 |
Apple
AAPL
|
$1.81M |
| 3 |
Schwab US TIPS ETF
SCHP
|
$899K |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
$701K |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
$574K |
Top Sells
| 1 |
Schwab Short-Term US Treasury ETF
SCHO
|
$1.91M |
| 2 |
Eli Lilly
LLY
|
$1.54M |
| 3 |
Waste Management
WM
|
$1.49M |
| 4 |
FLG
Flagstar Financial, Inc.
FLG
|
$1.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
$808K |
Sector Composition
| 1 | Healthcare | 3.66% |
| 2 | Technology | 2.84% |
| 3 | Consumer Discretionary | 1.65% |
| 4 | Materials | 1.61% |
| 5 | Financials | 0.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amazon
AMZN
$2.4T
| $831K | 0.67% |
264
+2
| +0.8% | +$6.3K |
|
27
Vanguard S&P 500 ETF
VOO
$720B
| $784K | 0.63% |
2,548
-400
| -14% | -$123K |
|
|
RETA
28
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $738K | 0.6% |
7,574
-504
| -6% | -$49.1K |
|
29
Sprott Physical Silver Trust
PSLV
$7.61B
| $727K | 0.59% |
87,906
+10,834
| +14% | +$89.6K |
|
30
Pan American Silver
PAAS
$12.4B
| $666K | 0.54% |
20,727
-12,266
| -37% | -$394K |
|
31
Vanguard Small-Cap Value ETF
VBR
$31.2B
| $665K | 0.54% |
6,012
| – | – |
|
32
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $570K | 0.46% |
13,924
| – | – |
|
|
KL
33
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $555K | 0.45% |
11,383
-7,204
| -39% | -$351K |
|
34
Sarepta Therapeutics
SRPT
$1.77B
| $529K | 0.43% |
3,767
+326
| +9% | +$45.8K |
|
|
PDX
35
PIMCO Dynamic Income Strategy Fund
PDX
$1.1B
| $509K | 0.41% |
82,268
+37,652
| +84% | +$233K |
|
36
Agnico Eagle Mines
AEM
$74.2B
| $483K | 0.39% |
6,064
-331
| -5% | -$26.4K |
|
37
iShares Russell 1000 Growth ETF
IWF
$115B
| $479K | 0.39% |
2,210
-61
| -3% | -$13.2K |
|
38
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$54B
| $474K | 0.38% |
4,949
| – | – |
|
39
Pfizer
PFE
$142B
| $445K | 0.36% |
12,112
-9,446
| -44% | -$347K |
|
40
Microsoft
MSFT
$3.75T
| $422K | 0.34% |
2,008
-50
| -2% | -$10.5K |
|
41
89bio
ETNB
$1.36B
| $420K | 0.34% |
16,359
+2,959
| +22% | +$76K |
|
42
Coca-Cola
KO
$297B
| $418K | 0.34% |
8,460
+118
| +1% | +$5.83K |
|
43
Vanguard Russell 3000 ETF
VTHR
$3.51B
| $388K | 0.31% |
2,550
| – | – |
|
44
Vanguard Russell 2000 Growth ETF
VTWG
$1.06B
| $387K | 0.31% |
2,398
| – | – |
|
45
Vanguard Small-Cap Growth ETF
VBK
$20B
| $365K | 0.29% |
1,699
| – | – |
|
46
Ascendis Pharma
ASND
$12.1B
| $356K | 0.29% |
2,305
+258
| +13% | +$39.8K |
|
47
ProShares UltraPro Short S&P 500
SPXU
$539M
| $339K | 0.27% |
39,000
-78,000
| -67% | -$678K |
|
48
BioNTech
BNTX
$24.2B
| $338K | 0.27% |
4,881
-2,635
| -35% | -$182K |
|
49
CRISPR Therapeutics
CRSP
$4.79B
| $320K | 0.26% |
3,830
+173
| +5% | +$14.5K |
|
50
Intel
INTC
$106B
| $318K | 0.26% |
6,148
-13,910
| -69% | -$719K |
|